The BARDA VITAL Prize (BVP) Challenge
The BVP challenge supports innovative vaccines, therapeutics, and related enabling technologies aligned with BARDA’s mission and strategic plan. We are on the hunt for original, out-of-the-box solutions without concern for their complexity or stage.
$45K in cash prizes will be awarded to companies or university-based projects for innovations in
- Vaccine and therapeutic platforms that allow for swift development, validation, and deployment
- Broad-spectrum antimicrobial therapeutics and vaccines including antivirals, antibacterials, and antifungals
- Vaccines and therapeutics with broad protection and enduring efficacy
- Treatments that modulate the host’s immune response (host-directed therapeutics)
- Enabling technologies that improve upon current vaccine and therapeutic efficacy, decrease production, storage, distribution costs, speed production, and improve access
Benefits For BVP Challenge Finalists
The BVP challenge finalists are invited to attend the BARDA VITAL Symposium in Berlin, Germany on June 27, 2024, where cash prize winners will be announced*
* Finalists must be present to win. Finalists must support their own travel-related expenses to attend the BARDA VITAL Symposium in Berlin.
BVP challenge finalists attending the BARDA VITAL Symposium receive the opportunity to:
- Network with representatives from BARDA, investors, the VITAL Hub, the European Commission Health Emergency Preparedness and Response (HERA), EIT-Health, industry, the Charité and Berlin Institute of Health (BIH), and members of the U.S. and EU therapeutics and vaccine innovation community
- Pitch in front of all Symposium attendees to compete for the cash prizes
- Meet 1:1 with BARDA team
- Meet 1:1 with biotech investors
- Meet 1:1 with biotech mentors
- Receive pitch training and investor deck feedback
Quelle: Prize Challenge – VITAL Hub (vitalhubhealth.com)
